Northwest Biotherapeutics, Inc.
NWBO
$0.25
$0.00-0.83%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -33.33% | 5.65% | 55.31% | 27.77% | -26.00% |
| Total Receivables | 0.00% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -6.92% | 26.54% | -3.57% | 1.06% | -16.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -23.35% | 16.95% | 31.35% | 15.36% | -21.76% |
|
|
|||||
| Total Current Assets | -23.35% | 16.95% | 31.35% | 15.36% | -21.76% |
| Net Property, Plant & Equipment | 2.21% | 0.15% | 2.78% | 0.74% | -6.66% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 4,016.72% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.56% | -3.24% | 0.82% | 0.55% | -2.41% |
| Total Assets | 165.58% | 3.59% | 7.42% | 2.91% | -8.84% |
|
|
|||||
| Total Accounts Payable | 14.66% | 13.59% | 14.02% | 22.28% | -5.27% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -30.23% | -16.81% | -16.95% | 38.46% | 87.22% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 21.47% | 4.98% | 4.66% | 20.76% | -4.38% |
| Total Finance Division Other Current Liabilities | -9.34% | 12.32% | 0.71% | 47.27% | -3.69% |
| Total Other Current Liabilities | -9.34% | 12.32% | 0.71% | 47.27% | -3.69% |
| Total Current Liabilities | 4.32% | 4.75% | 1.04% | 21.66% | 14.62% |
|
|
|||||
| Total Current Liabilities | 4.32% | 4.75% | 1.04% | 21.66% | 14.62% |
| Long-Term Debt | -43.79% | 38.66% | 14.05% | -28.92% | 15.64% |
| Short-term Debt | -30.23% | -16.81% | -16.95% | 38.46% | 87.22% |
| Capital Leases | -0.81% | -3.83% | 3.42% | 0.74% | -8.08% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 774.76% | -63.83% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | 2.39% | 8.33% | 3.42% | 6.28% | 12.98% |
|
|
|||||
| Common Stock & APIC | 3.34% | 1.30% | 1.30% | 1.19% | 0.81% |
| Retained Earnings | 0.09% | -1.81% | -1.05% | -1.34% | -1.99% |
| Treasury Stock & Other | 21.60% | 32.78% | -246.06% | -55.47% | 2,844.44% |
| Total Common Equity | 44.52% | -8.23% | -0.91% | -5.28% | -17.94% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -5.15% | -2.57% | -6.07% | -5.58% | -2.33% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -5.15% | -2.57% | -6.07% | -5.58% | -2.33% |
|
|
|||||
| Total Common Equity | 44.52% | -8.23% | -0.91% | -5.28% | -17.94% |
| Total Preferred Equity | -5.15% | -2.57% | -6.07% | -5.58% | -2.33% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 50.06% | -9.94% | -2.12% | -7.42% | -22.95% |
|
|
|||||